Compare TTC & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTC | RDY |
|---|---|---|
| Founded | 1914 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Tools/Hardware | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.9B |
| IPO Year | 1994 | 2001 |
| Metric | TTC | RDY |
|---|---|---|
| Price | $100.06 | $12.22 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 1 |
| Target Price | ★ $104.00 | $16.90 |
| AVG Volume (30 Days) | 525.9K | ★ 2.6M |
| Earning Date | 06-04-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.66% | 0.52% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.18 | N/A |
| Revenue | ★ $2,618,650,000.00 | N/A |
| Revenue This Year | $6.13 | $7.72 |
| Revenue Next Year | $4.45 | $3.50 |
| P/E Ratio | $45.67 | ★ $18.67 |
| Revenue Growth | ★ 4.53 | N/A |
| 52 Week Low | $67.64 | $11.36 |
| 52 Week High | $105.19 | $15.67 |
| Indicator | TTC | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 61.07 | 45.56 |
| Support Level | $91.43 | $12.09 |
| Resistance Level | $101.31 | $12.58 |
| Average True Range (ATR) | 2.05 | 0.20 |
| MACD | 0.13 | 0.06 |
| Stochastic Oscillator | 86.35 | 62.50 |
The Toro Co designs, manufactures, markets, and sells professional turf maintenance equipment and services; turf and agricultural irrigation systems; landscaping equipment and lighting products; snow and ice management equipment; construction equipment; and residential yard and snow thrower products. The company operates through Professional and Residential segments, with the Professional segment serving commercial, agricultural, and construction customers and generating the majority of revenue, while the Residential segment focuses on homeowners. Its products are sold through distributors, dealers, retailers, rental centers, and direct channels, with the United States as its primary revenue-generating market.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.